Inpatient costs and charges for surgical treatment of hypoplastic left heart syndrome

Peter N Dean1, Diane G Hillman, Kimberly E McHugh

  • 1Department of Pediatrics, University of Virginia Health System, Charlottesville, VA 22908-0386, USA.

Pediatrics
|October 12, 2011
PubMed

Insights

Hypoplastic left heart syndrome (HLHS) care is resource-intensive, involving complex surgeries or transplants. Rising survival rates for HLHS patients have significantly increased hospital stays and associated costs.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Healthcare Resource Utilization

Background:

  • Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect requiring complex management.
  • Treatment typically involves staged palliative surgeries (Norwood-Glenn-Fontan pathway) or cardiac transplantation.
  • Quantifying the inpatient resource burden is crucial for healthcare planning.

Purpose of the Study:

  • To quantify the inpatient resource utilization for HLHS patients.
  • To compare resource demands across different treatment strategies (staged palliation vs. transplantation).
  • To analyze trends in resource use over time.

Main Methods:

  • Utilized data from the University HealthSystem Consortium, encompassing 101 academic medical centers.
  • Analyzed inpatient resource use for HLHS patients undergoing staged palliation or transplantation from 1998 to 2007.
  • Examined length of stay (LOS) and financial charges associated with each treatment pathway.

Main Results:

  • Stage 1 palliation (Norwood/Sano) had a median LOS of 25 days and charges of $214,680.
  • Neonatal transplantation had a median LOS of 87 days and charges of $582,920.
  • Between 1998 and 2007, LOS for stage 1 palliation increased from 16 to 28 days, with inflation-adjusted charges rising significantly due to improved survival rates (57% to 83%).

Conclusions:

  • HLHS patients incur substantial inpatient resource burdens, irrespective of treatment via the Norwood-Glenn-Fontan pathway or transplantation.
  • Increasing survival rates for HLHS are associated with longer hospital stays and higher healthcare costs.
  • Effective resource management strategies are essential for addressing the growing demands of HLHS care.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...